HOME / Notice / News / EN
The Human Immune Center with the Automatic Culture System of Personalized NK Cells Opened in February NKCL Bio Group Inc. (hereinafter referred to as NKCL Bio Group), a company specializing in “Personalized Immune Care”, hosts the the 1st Thanks Day for its partners at Grand Ballroom of Grand Hyatt...
NKCL Bio Group’s NK Immune Water has won the Grand Prize in the deep sea water category at the ‘2022 Customers Most Recommended Brand Awards’ hosted and sponsored by The JoongAng and The Economist on the 20th this month. The awards select the brands that have been certified by customers for its re...
NKCL Bio Group researches and develops NK cell therapeutics using the technology of culture method for autologous immune cells, which maintains the same quality of cell therapy products. We are leading the universalization of NK cell therapeutics by establishing a GMP automatic culture system that en...
NKCL Bio Group, exclusive license and its contents NKCL Bio Group has secured an exclusive license by signing a contract for a patent-exclusive license. Exclusive license refers to the right of the patentee, etc. to exclusively use the patented invention as a business within the scope of a contract w...
Last thirtieth of November, NKCL Bio Group Inc. won the ninth 2021 Future Creative Superiority Company Grand Award in the Innovative Immune Cell Cultivation Technology Field for the second time in a row. ‘Future Creative Superiority Company Grand Award’ is an award to discover and select companies ...